Roswit B, Higgins G A, Keehn R J
Cancer. 1975 Jun;35(6):1597-602. doi: 10.1002/1097-0142(197506)35:6<1597::aid-cncr2820350618>3.0.co;2-s.
In 1964 the Veterans Administration Surgical Adjuvant Group (VASAG) initiated a large-scale, controlled, randomized protocol to study the role of low-dose preoperative irradiation (2000-2500 rads/10fractions/12 days) in patients with operable adenocarcinoma of the sigmoid colon and rectum. This report analyzes the data in 700 patients, all at 5-year risk. There appears to be a definate benefit to irradiated patients who undergo abdominoperineal resections, when compared with the controls. This advantage is reflected in improvement of 5-year survival, and reduction in lymph node invasion, local recurrence, and distant metastases. A second protocol has been initiated in 30 VA hospitals employing a higher dose (3150 rads) to extended portals (toL2) to male patients who require abdominoperineal resections.
1964年,退伍军人管理局外科辅助治疗小组(VASAG)启动了一项大规模、对照、随机方案,以研究低剂量术前放疗(2000 - 2500拉德/10次分割/12天)在可手术的乙状结肠癌和直肠癌患者中的作用。本报告分析了700例患者的数据,所有患者均处于5年风险期。与对照组相比,接受腹会阴切除术的放疗患者似乎有明确的益处。这种优势体现在5年生存率的提高、淋巴结侵犯、局部复发和远处转移的减少。第二项方案已在30家退伍军人管理局医院启动,对需要接受腹会阴切除术的男性患者采用更高剂量(3150拉德)照射扩大野(至L2)。